Achieve Life Sciences Inc. Common Shares (ACHV)
ACHV trades on Nasdaq in Health Care, Biotechnology: In Vitro & In Vivo Diagnostic Substances. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.00
-0.85% on the day
Market cap
$720.3M
Small cap
Revenue
No annual revenue filed since the period ending 2019-12-31
Net income
No annual revenue filed since the period ending 2019-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ACHV on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000949858 |
| SEC industry code | In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2019-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-08-14 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-10-01 |
| Latest proxy | DEF 14A | 2026-06-08 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.3% |
| 1 month | -4.4% |
| 3 months | +17.4% |
| Year to date | +40.8% |
| 1 year | +125.8% |
| From 52-week high | -17.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: In Vitro & In Vivo Diagnostic Substances
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NNNN | Anbio Biotechnology | $4.26 | -3.40% | $613.0M |
| QDEL | QuidelOrtho Corporation | $14.10 | +6.42% | $966.9M |
| TKNO | Alpha Teknova Inc. | $8.22 | -5.52% | $441.3M |
| MYGN | Myriad Genetics Inc. | $4.08 | -2.86% | $390.3M |
| NTLA | Intellia Therapeutics Inc. | $11.91 | -5.33% | $1.7B |
| CLDX | Celldex Therapeutics Inc. | $28.25 | -4.01% | $2.2B |
| NEOG | Neogen Corporation | $11.73 | -2.25% | $2.6B |
| ORKA | Oruka Therapeutics Inc. | $78.19 | -2.69% | $5.2B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier